nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0723	0.0852	CbGbCtD
Tolbutamide—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0564	0.0664	CbGbCtD
Tolbutamide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0548	0.0646	CbGbCtD
Tolbutamide—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0547	0.0645	CbGbCtD
Tolbutamide—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0495	0.0583	CbGbCtD
Tolbutamide—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0495	0.0583	CbGbCtD
Tolbutamide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0288	0.0339	CbGbCtD
Tolbutamide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0261	0.0307	CbGbCtD
Tolbutamide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0261	0.0307	CbGbCtD
Tolbutamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0257	0.0303	CbGbCtD
Tolbutamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0242	0.0285	CbGbCtD
Tolbutamide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0223	0.0262	CbGbCtD
Tolbutamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0219	0.0258	CbGbCtD
Tolbutamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0219	0.0258	CbGbCtD
Tolbutamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0214	0.0252	CbGbCtD
Tolbutamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0201	0.0237	CbGbCtD
Tolbutamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0201	0.0237	CbGbCtD
Tolbutamide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0198	0.0233	CbGbCtD
Tolbutamide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0198	0.0233	CbGbCtD
Tolbutamide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0189	0.0223	CbGbCtD
Tolbutamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0189	0.0223	CbGbCtD
Tolbutamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0183	0.0216	CbGbCtD
Tolbutamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0182	0.0214	CbGbCtD
Tolbutamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0182	0.0214	CbGbCtD
Tolbutamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0166	0.0195	CbGbCtD
Tolbutamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0166	0.0195	CbGbCtD
Tolbutamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0159	0.0187	CbGbCtD
Tolbutamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0157	0.0185	CbGbCtD
Tolbutamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.018	CbGbCtD
Tolbutamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0138	0.0162	CbGbCtD
Tolbutamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0162	CbGbCtD
Tolbutamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0132	0.0156	CbGbCtD
Tolbutamide—Alcohol intolerance—Efavirenz—acquired immunodeficiency syndrome	0.00511	0.0439	CcSEcCtD
Tolbutamide—Alcohol intolerance—Delavirdine—acquired immunodeficiency syndrome	0.00489	0.042	CcSEcCtD
Tolbutamide—Alcohol intolerance—Ritonavir—acquired immunodeficiency syndrome	0.00452	0.0388	CcSEcCtD
Tolbutamide—Eruption—Efavirenz—acquired immunodeficiency syndrome	0.00264	0.0227	CcSEcCtD
Tolbutamide—Heartburn—Saquinavir—acquired immunodeficiency syndrome	0.00201	0.0173	CcSEcCtD
Tolbutamide—Aplastic anaemia—Abacavir—acquired immunodeficiency syndrome	0.00197	0.0169	CcSEcCtD
Tolbutamide—Hypoglycaemia—Didanosine—acquired immunodeficiency syndrome	0.00182	0.0156	CcSEcCtD
Tolbutamide—Aplastic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00174	0.0149	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.014	CcSEcCtD
Tolbutamide—Hypoglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00159	0.0136	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00149	0.0128	CcSEcCtD
Tolbutamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00144	0.0418	CbGeAlD
Tolbutamide—Haemolytic anaemia—Indinavir—acquired immunodeficiency syndrome	0.00138	0.0119	CcSEcCtD
Tolbutamide—Abdominal distension—Nelfinavir—acquired immunodeficiency syndrome	0.00135	0.0116	CcSEcCtD
Tolbutamide—KCNJ1—nervous system—acquired immunodeficiency syndrome	0.00133	0.0386	CbGeAlD
Tolbutamide—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.0013	0.0378	CbGeAlD
Tolbutamide—KCNJ1—central nervous system—acquired immunodeficiency syndrome	0.00128	0.0371	CbGeAlD
Tolbutamide—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00128	0.011	CcSEcCtD
Tolbutamide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00126	0.0365	CbGeAlD
Tolbutamide—Haemolytic anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00125	0.0107	CcSEcCtD
Tolbutamide—Aplastic anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.0106	CcSEcCtD
Tolbutamide—CYP2C18—vagina—acquired immunodeficiency syndrome	0.00115	0.0334	CbGeAlD
Tolbutamide—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00115	0.00987	CcSEcCtD
Tolbutamide—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00973	CcSEcCtD
Tolbutamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0324	CbGeAlD
Tolbutamide—Haemolytic anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00955	CcSEcCtD
Tolbutamide—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00946	CcSEcCtD
Tolbutamide—Abdominal distension—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00932	CcSEcCtD
Tolbutamide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.00106	0.0306	CbGeAlD
Tolbutamide—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00884	CcSEcCtD
Tolbutamide—Abdominal distension—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00881	CcSEcCtD
Tolbutamide—KCNJ1—brain—acquired immunodeficiency syndrome	0.00102	0.0295	CbGeAlD
Tolbutamide—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00866	CcSEcCtD
Tolbutamide—Abdominal distension—Delavirdine—acquired immunodeficiency syndrome	0.000982	0.00843	CcSEcCtD
Tolbutamide—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000982	0.00843	CcSEcCtD
Tolbutamide—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000968	0.00831	CcSEcCtD
Tolbutamide—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.000965	0.00829	CcSEcCtD
Tolbutamide—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.000963	0.00827	CcSEcCtD
Tolbutamide—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000959	0.00823	CcSEcCtD
Tolbutamide—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000933	0.00801	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.00093	0.00799	CcSEcCtD
Tolbutamide—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.00795	CcSEcCtD
Tolbutamide—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000919	0.0266	CbGeAlD
Tolbutamide—Abdominal distension—Ritonavir—acquired immunodeficiency syndrome	0.000908	0.00779	CcSEcCtD
Tolbutamide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.000883	0.0256	CbGeAlD
Tolbutamide—Abdominal distension—Saquinavir—acquired immunodeficiency syndrome	0.000874	0.0075	CcSEcCtD
Tolbutamide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000856	0.00735	CcSEcCtD
Tolbutamide—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000835	0.00717	CcSEcCtD
Tolbutamide—Abdominal distension—Lamivudine—acquired immunodeficiency syndrome	0.000834	0.00716	CcSEcCtD
Tolbutamide—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000832	0.00715	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000828	0.00711	CcSEcCtD
Tolbutamide—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.00708	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000823	0.00707	CcSEcCtD
Tolbutamide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00082	0.00704	CcSEcCtD
Tolbutamide—SLC15A2—retina—acquired immunodeficiency syndrome	0.000818	0.0237	CbGeAlD
Tolbutamide—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000812	0.0235	CbGeAlD
Tolbutamide—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000808	0.00694	CcSEcCtD
Tolbutamide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.000807	0.0234	CbGeAlD
Tolbutamide—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000792	0.0068	CcSEcCtD
Tolbutamide—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00675	CcSEcCtD
Tolbutamide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.000777	0.0225	CbGeAlD
Tolbutamide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00077	0.00661	CcSEcCtD
Tolbutamide—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000769	0.00661	CcSEcCtD
Tolbutamide—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.000753	0.0218	CbGeAlD
Tolbutamide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000745	0.0064	CcSEcCtD
Tolbutamide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.000744	0.0215	CbGeAlD
Tolbutamide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000743	0.00638	CcSEcCtD
Tolbutamide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000732	0.00628	CcSEcCtD
Tolbutamide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000723	0.00621	CcSEcCtD
Tolbutamide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.000716	0.0207	CbGeAlD
Tolbutamide—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00071	0.0061	CcSEcCtD
Tolbutamide—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000693	0.0201	CbGeAlD
Tolbutamide—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.000691	0.02	CbGeAlD
Tolbutamide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000689	0.00592	CcSEcCtD
Tolbutamide—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000679	0.00583	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000679	0.00583	CcSEcCtD
Tolbutamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000678	0.00582	CcSEcCtD
Tolbutamide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00067	0.00575	CcSEcCtD
Tolbutamide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000668	0.00574	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000657	0.00564	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000655	0.00563	CcSEcCtD
Tolbutamide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000653	0.0189	CbGeAlD
Tolbutamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000646	0.00555	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000645	0.00554	CcSEcCtD
Tolbutamide—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000636	0.0184	CbGeAlD
Tolbutamide—SLCO2B1—lung—acquired immunodeficiency syndrome	0.000629	0.0182	CbGeAlD
Tolbutamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000624	0.00536	CcSEcCtD
Tolbutamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000618	0.00531	CcSEcCtD
Tolbutamide—KCNJ11—brain—acquired immunodeficiency syndrome	0.000617	0.0179	CbGeAlD
Tolbutamide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000608	0.00522	CcSEcCtD
Tolbutamide—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.00519	CcSEcCtD
Tolbutamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000605	0.00519	CcSEcCtD
Tolbutamide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000605	0.00519	CcSEcCtD
Tolbutamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000603	0.00518	CcSEcCtD
Tolbutamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000601	0.00516	CcSEcCtD
Tolbutamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000601	0.00516	CcSEcCtD
Tolbutamide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000596	0.0173	CbGeAlD
Tolbutamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000594	0.0051	CcSEcCtD
Tolbutamide—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000582	0.0169	CbGeAlD
Tolbutamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000581	0.00499	CcSEcCtD
Tolbutamide—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000578	0.0168	CbGeAlD
Tolbutamide—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.00495	CcSEcCtD
Tolbutamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00057	0.00489	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000569	0.00489	CcSEcCtD
Tolbutamide—ABCC8—brain—acquired immunodeficiency syndrome	0.000568	0.0165	CbGeAlD
Tolbutamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000567	0.00487	CcSEcCtD
Tolbutamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000562	0.00483	CcSEcCtD
Tolbutamide—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.00056	0.0162	CbGeAlD
Tolbutamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000556	0.00477	CcSEcCtD
Tolbutamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000554	0.0161	CbGeAlD
Tolbutamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000551	0.00473	CcSEcCtD
Tolbutamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000548	0.0047	CcSEcCtD
Tolbutamide—SLC15A2—blood—acquired immunodeficiency syndrome	0.000548	0.0159	CbGeAlD
Tolbutamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000543	0.00466	CcSEcCtD
Tolbutamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000541	0.00465	CcSEcCtD
Tolbutamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00054	0.00464	CcSEcCtD
Tolbutamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000539	0.00462	CcSEcCtD
Tolbutamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000537	0.00461	CcSEcCtD
Tolbutamide—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000536	0.0155	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00053	0.00455	CcSEcCtD
Tolbutamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000529	0.00454	CcSEcCtD
Tolbutamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000528	0.0153	CbGeAlD
Tolbutamide—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000527	0.0153	CbGeAlD
Tolbutamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000524	0.0045	CcSEcCtD
Tolbutamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000519	0.00446	CcSEcCtD
Tolbutamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000516	0.00443	CcSEcCtD
Tolbutamide—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000516	0.0149	CbGeAlD
Tolbutamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00051	0.00438	CcSEcCtD
Tolbutamide—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000508	0.0147	CbGeAlD
Tolbutamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000502	0.00431	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.0005	0.0043	CcSEcCtD
Tolbutamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000496	0.00426	CcSEcCtD
Tolbutamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000492	0.00423	CcSEcCtD
Tolbutamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00049	0.0142	CbGeAlD
Tolbutamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000488	0.00419	CcSEcCtD
Tolbutamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000487	0.00418	CcSEcCtD
Tolbutamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000483	0.00415	CcSEcCtD
Tolbutamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00048	0.00412	CcSEcCtD
Tolbutamide—SLC15A2—lung—acquired immunodeficiency syndrome	0.00048	0.0139	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00411	CcSEcCtD
Tolbutamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000479	0.00411	CcSEcCtD
Tolbutamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000477	0.00409	CcSEcCtD
Tolbutamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000475	0.00408	CcSEcCtD
Tolbutamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000471	0.00405	CcSEcCtD
Tolbutamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000468	0.00402	CcSEcCtD
Tolbutamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000467	0.00401	CcSEcCtD
Tolbutamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000467	0.00401	CcSEcCtD
Tolbutamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000461	0.00396	CcSEcCtD
Tolbutamide—CYP2C8—blood—acquired immunodeficiency syndrome	0.000461	0.0134	CbGeAlD
Tolbutamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00046	0.00395	CcSEcCtD
Tolbutamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000452	0.00388	CcSEcCtD
Tolbutamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000451	0.00388	CcSEcCtD
Tolbutamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00387	CcSEcCtD
Tolbutamide—SLCO2B1—brain—acquired immunodeficiency syndrome	0.000445	0.0129	CbGeAlD
Tolbutamide—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000444	0.0129	CbGeAlD
Tolbutamide—Gliclazide—ALB—acquired immunodeficiency syndrome	0.000444	0.609	CrCbGaD
Tolbutamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000444	0.00381	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.0038	CcSEcCtD
Tolbutamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000441	0.00378	CcSEcCtD
Tolbutamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00373	CcSEcCtD
Tolbutamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000434	0.00373	CcSEcCtD
Tolbutamide—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.00043	0.0125	CbGeAlD
Tolbutamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00043	0.0125	CbGeAlD
Tolbutamide—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000428	0.0124	CbGeAlD
Tolbutamide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000427	0.0124	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000426	0.00366	CcSEcCtD
Tolbutamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000416	0.00357	CcSEcCtD
Tolbutamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.00356	CcSEcCtD
Tolbutamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000413	0.00355	CcSEcCtD
Tolbutamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00041	0.00352	CcSEcCtD
Tolbutamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000409	0.0119	CbGeAlD
Tolbutamide—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000409	0.0119	CbGeAlD
Tolbutamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.0035	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00349	CcSEcCtD
Tolbutamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000392	0.00337	CcSEcCtD
Tolbutamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000392	0.00337	CcSEcCtD
Tolbutamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00336	CcSEcCtD
Tolbutamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000387	0.00332	CcSEcCtD
Tolbutamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000384	0.0033	CcSEcCtD
Tolbutamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000374	0.00321	CcSEcCtD
Tolbutamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000365	0.00314	CcSEcCtD
Tolbutamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00313	CcSEcCtD
Tolbutamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00312	CcSEcCtD
Tolbutamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000363	0.00312	CcSEcCtD
Tolbutamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00035	0.003	CcSEcCtD
Tolbutamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000349	0.003	CcSEcCtD
Tolbutamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000347	0.00298	CcSEcCtD
Tolbutamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00296	CcSEcCtD
Tolbutamide—SLC15A2—brain—acquired immunodeficiency syndrome	0.00034	0.00984	CbGeAlD
Tolbutamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000333	0.00286	CcSEcCtD
Tolbutamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00283	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000328	0.00951	CbGeAlD
Tolbutamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.00278	CcSEcCtD
Tolbutamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00276	CcSEcCtD
Tolbutamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.00267	CcSEcCtD
Tolbutamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00265	CcSEcCtD
Tolbutamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00262	CcSEcCtD
Tolbutamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00255	CcSEcCtD
Tolbutamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00253	CcSEcCtD
Tolbutamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00252	CcSEcCtD
Tolbutamide—CYP2C8—brain—acquired immunodeficiency syndrome	0.000286	0.00829	CbGeAlD
Tolbutamide—Probenecid—ALB—acquired immunodeficiency syndrome	0.000285	0.391	CrCbGaD
Tolbutamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.0024	CcSEcCtD
